COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review

The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS−COV-2), generated an unprecedented global health and social emergency. Despite many efforts from clinicians to develop effective anti−COVID-19 treatment protocols, no specific therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Franchini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839625/
https://www.ncbi.nlm.nih.gov/pubmed/33518427
http://dx.doi.org/10.1016/j.transci.2021.103071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839625/
https://www.ncbi.nlm.nih.gov/pubmed/33518427
http://dx.doi.org/10.1016/j.transci.2021.103071

Ejemplares similares